These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29122824)

  • 1. Ruthenium-106 brachytherapy for iris and iridociliary melanomas.
    Marinkovic M; Horeweg N; Laman MS; Bleeker JC; Ketelaars M; Peters FP; Luyten GPM; Creutzberg CL
    Br J Ophthalmol; 2018 Aug; 102(8):1154-1159. PubMed ID: 29122824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ruthenium plaque radiation therapy for iris and iridociliary melanomas.
    Razzaq L; Keunen JE; Schalij-Delfos NE; Creutzberg CL; Ketelaars M; de Keizer RJ
    Acta Ophthalmol; 2012 May; 90(3):291-6. PubMed ID: 20670343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irido-cilio-choroidal melanoma in a 5-year-old boy treated by Ru-106 brachytherapy.
    Pe'er J; Averbukh E; Frenkel S
    Clin Exp Ophthalmol; 2009 Sep; 37(7):742-3. PubMed ID: 19788674
    [No Abstract]   [Full Text] [Related]  

  • 4. Ruthenium plaque radiation for iris and iridociliary melanomas: development of dry eyes?
    Razzaq L; de Keizer RJ
    Br J Ophthalmol; 2010 Nov; 94(11):1549-50. PubMed ID: 20516146
    [No Abstract]   [Full Text] [Related]  

  • 5. Ruthenium-106 brachytherapy for choroidal melanoma without transpupillary thermotherapy: Similar efficacy with improved visual outcome.
    Marinkovic M; Horeweg N; Fiocco M; Peters FP; Sommers LW; Laman MS; Bleeker JC; Ketelaars M; Luyten GP; Creutzberg CL
    Eur J Cancer; 2016 Nov; 68():106-113. PubMed ID: 27741435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plaque radiation therapy for malignant melanoma of the iris and ciliary body.
    Finger PT
    Am J Ophthalmol; 2001 Sep; 132(3):328-35. PubMed ID: 11530044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
    Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
    Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Ruthenium-106 Brachytherapy for Iris Melanoma: The Scottish Experience.
    Agraval U; Sobti M; Russell HC; Lockington D; Ritchie D; Cauchi P; Kemp EG; Chadha V
    Br J Ophthalmol; 2018 Jan; 102(1):74-78. PubMed ID: 28600302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ruthenium-106 plaque brachytherapy for uveal melanoma.
    Tarmann L; Wackernagel W; Avian A; Mayer C; Schneider M; Winkler P; Langmann G
    Br J Ophthalmol; 2015 Dec; 99(12):1644-9. PubMed ID: 25979763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic disease, eye retention and visual function in conservative treatment of uveal melanoma.
    Bornfeld N; Chauvel P; Sauerwein W; Friedrichs W; Tiburtius T; Wessing A; Foerster MH
    Front Radiat Ther Oncol; 1997; 30():97-110. PubMed ID: 9205890
    [No Abstract]   [Full Text] [Related]  

  • 12. [Plaque radiotherapy for anterior uveal melanomas].
    Saakyan SV; Amiryan AG; Valskiy VV; Mironova IS
    Vestn Oftalmol; 2015; 131(2):5-12. PubMed ID: 26080576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound biomicroscopy features of iris and ciliary body melanomas before and after brachytherapy.
    Torres VL; Allemann N; Erwenne CM
    Ophthalmic Surg Lasers Imaging; 2005; 36(2):129-38. PubMed ID: 15792314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciliary body melanoma with limited nodular extrascleral extension and diffuse iris-angle infiltration treated by whole anterior segment plaque radiotherapy.
    Gray ME; Corrêa ZM; Augsburger JJ; Barrett W
    Int Ophthalmol; 2007 Aug; 27(4):273-6. PubMed ID: 17468833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanoma.
    Lommatzsch PK; Werschnik C; Schuster E
    Graefes Arch Clin Exp Ophthalmol; 2000 Feb; 238(2):129-37. PubMed ID: 10766281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plaque radiotherapy treatment with ruthenium-106 for iris malignant melanoma.
    Tsimpida M; Hungerford J; Arora A; Cohen V
    Eye (Lond); 2011 Dec; 25(12):1607-11. PubMed ID: 21941358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of ciliary body melanoma with iodine-125 plaque brachytherapy.
    Krema H; Simpson ER; Pavlin CJ; Payne D; Vasquez LM; McGowan H
    Can J Ophthalmol; 2009 Aug; 44(4):395-400. PubMed ID: 19606159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [High-dose 106Ruthenium plaque brachytherapy for posterior uveal melanoma. A clinico-pathologic study].
    Heindl LM; Lotter M; Strnad V; Sauer R; Naumann GO; Knorr HL
    Ophthalmologe; 2007 Feb; 104(2):149-57. PubMed ID: 17123048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
    Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
    Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plaque radiotherapy for management of ciliary body and choroidal melanoma with extraocular extension.
    Gündüz K; Shields CL; Shields JA; Cater J; Brady L
    Am J Ophthalmol; 2000 Jul; 130(1):97-102. PubMed ID: 11004266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.